Literature DB >> 30311061

Efficacy of a drug composed of herbal extracts on postoperative discomfort after surgical removal of impacted mandibular third molar: a randomized, triple-blind, controlled clinical trial.

Gaetano Isola1,2, Marco Matarese3, Luca Ramaglia4, Vincenzo Iorio-Siciliano4, Giancarlo Cordasco3, Giovanni Matarese3.   

Abstract

OBJECTIVES: This study investigated and compared the effectiveness of a phytotherapeutic drug composed of herbal extracts on postsurgical discomfort after mandibular third molar surgery.
MATERIALS AND METHODS: Eighty-two patients requiring the surgical removal of a mandibular third molar were randomly assigned to receive placebo (group 1), ibuprofen (group 2), and a phytotherapeutic drug (composed of baicalin, 190 mg; bromelain, 50 mg; escin, 30 mg) (group 3). Drugs were administered after tooth extraction twice a day for 5 days. The primary outcome, pain, was evaluated using a visual analogue scale at 2 h, 6 h, 12 h, 24 h, 48 h, and 7 and 10 days after surgery. The secondary outcomes were the changes in maximum mouth opening and facial contours (mm) between baseline and at 24 h, 72 h, and 7 and 10 days after surgery.
RESULTS: Compared to the baseline, all treatments demonstrated an improvement in the primary and secondary outcomes. Moreover, compared to groups 1 and 2, patients in group 3 yielded a significant reduction of the postoperative pain score at 12 h (p < 0.001), 24 h (p = 0.010), and 48 h (p = 0.048) after surgery. The mean reduction of the swelling and trismus was similar between groups.
CONCLUSIONS: The results of this study suggest that a postoperative administration of a phytotherapeutic drug was found to be effective in postoperative pain management after the surgical removal of impacted mandibular third molars. CLINICAL RELEVANCE: The phytotherapeutic drug composed of herbal extract determined a decrease in the severity of postoperative pain compared to ibuprofen and placebo.

Entities:  

Keywords:  Ibuprofen; Pain; Phytotherapeutic drug; Swelling; Third molar surgery; Trismus

Year:  2018        PMID: 30311061     DOI: 10.1007/s00784-018-2690-9

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  21 in total

1.  Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice.

Authors:  Gian Franco Cupido; Matteo Gelardi; Ignazio La Mantia; Salvo Emanuele Aragona; Claudio Vicini; Giorgio Ciprandi; Italian Study Group On Inflammatory Otorhinolaryngological Disorders
Journal:  Acta Biomed       Date:  2019-07-10

2.  Piceatannol Increases Antioxidant Defense and Reduces Cell Death in Human Periodontal Ligament Fibroblast under Oxidative Stress.

Authors:  Flávia Póvoa da Costa; Bruna Puty; Lygia S Nogueira; Geovanni Pereira Mitre; Sávio Monteiro Dos Santos; Bruno José Brito Teixeira; Maria Sueli da Silva Kataoka; Manoela Domingues Martins; Carlos Augusto Galvão Barboza; Marta Chagas Monteiro; Hervé Rogez; Edivaldo Herculano Corrêa de Oliveira; Rafael Rodrigues Lima
Journal:  Antioxidants (Basel)       Date:  2019-12-23

3.  Current Evidence of Natural Agents in Oral and Periodontal Health.

Authors:  Gaetano Isola
Journal:  Nutrients       Date:  2020-02-24       Impact factor: 5.717

4.  Periodontitis and Tooth Loss Have Negative Systemic Impact on Circulating Progenitor Cell Levels: A Clinical Study.

Authors:  Gaetano Isola; Antonino Lo Giudice; Alessandro Polizzi; Angela Alibrandi; Romeo Patini; Sebastiano Ferlito
Journal:  Genes (Basel)       Date:  2019-12-07       Impact factor: 4.096

5.  Solidago virgaurea L. Plant Extract Targeted Against Candida albicans to Reduce Oral Microbial Biomass: a Double Blind Randomized Trial on Healthy Adults.

Authors:  Isabelle Prêcheur; Yohan Rolland; Lilia Hasseine; François Orange; Adeline Morisot; Anne Landreau
Journal:  Antibiotics (Basel)       Date:  2020-03-25

6.  Effect of concentrated growth factors on frequency of alveolar Osteitis following partially-erupted mandibular third molar surgery: a randomized controlled clinical study.

Authors:  Banu Özveri Koyuncu; Gözde Işık; Meltem Özden Yüce; Sevtap Günbay; Tayfun Günbay
Journal:  BMC Oral Health       Date:  2020-08-17       Impact factor: 2.757

7.  Analysis of by high-throughput sequencing: Helicobacter pylori infection and salivary microbiome.

Authors:  Yingjie Ji; Xiao Liang; Hong Lu
Journal:  BMC Oral Health       Date:  2020-03-20       Impact factor: 2.757

Review 8.  Antibiotic Prophylaxis on Third Molar Extraction: Systematic Review of Recent Data.

Authors:  Gabriele Cervino; Marco Cicciù; Antonio Biondi; Salvatore Bocchieri; Alan Scott Herford; Luigi Laino; Luca Fiorillo
Journal:  Antibiotics (Basel)       Date:  2019-05-02

9.  Interleukin-10 and Interleukin-1β Cytokines Expression in Leukocytes of Patients with Chronic Peri-Mucositis.

Authors:  Darius Gleiznys; Alvydas Gleiznys; Lina Abraškevičiūtė; Astra Vitkauskienė; Viktoras Šaferis; Jurgina Sakalauskienė
Journal:  Med Sci Monit       Date:  2019-10-05

10.  Antibiotics and Antimicrobials for Treatment of the Oral Microbiota: Myths and Facts in Research and Clinical Practice.

Authors:  Gaetano Isola
Journal:  Antibiotics (Basel)       Date:  2020-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.